Natera, INC Form 4 insider transactions

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Michael Brophy, CFO of Natera, Inc., reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Natera's CEO, Steven Chapman, sold 4,523 shares of common stock on October 15, 2024, at a weighted average price of $130.3995 per share, according to a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., executed multiple sales of common stock on October 1, 2024, under pre-arranged Rule 10b5-1 trading plans.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on September 18, 2024, under pre-arranged Rule 10b5-1 trading plans.

Natera's CEO, Steven Leonard Chapman, sold shares of the company's common stock on September 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Rowan E. Chapman exercised stock options and sold shares of Natera, Inc. on September 13, 2024.

Natera's CEO, Steven Chapman, sold a portion of his common stock holdings on August 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold 12,000 shares of common stock at an average price of $121.0104 on August 15, 2024, according to a Form 4 filing.

Jonathan Sheena, co-founder of Natera, Inc., sold a portion of his common stock holdings on August 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

John Fesko, President and Chief Business Officer of Natera, Inc., reports acquisition and disposal of company stock related to RSU vesting.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., reports exercising stock options and changes in beneficial ownership of common stock.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 1,057 shares of common stock on July 29, 2024, to cover tax withholding obligations related to vesting RSUs.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of common stock on July 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., reported the sale of 929 shares of common stock and the exercise of an option for 100 shares.

Natera's CEO, Steven Chapman, sold 4,084 shares of common stock on July 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Michael Brophy, CFO of Natera, Inc., sold shares of common stock to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Director Herm Rosenman acquired 206 shares of Natera, Inc. common stock on July 26, 2024, through the issuance of fully vested RSUs in lieu of quarterly retainer fees.

Director James Healy acquired 177 shares of Natera, Inc. common stock in lieu of quarterly retainer fees.

Director Roelof Botha acquired 234 shares of Natera, Inc. common stock through the issuance of fully vested RSUs in lieu of quarterly retainer fees.

Director Roy D. Baynes acquired 143 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.

Natera's CFO, Michael Brophy, executed multiple sales of common stock between July 24 and July 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 549 shares of common stock on July 22, 2024, to satisfy tax withholding obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 549 shares of common stock on July 22, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Jonathan Sheena, co-founder of Natera, Inc., reports transactions involving restricted stock units and common stock.

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., reports transactions involving common stock and restricted stock units.

Natera's CEO, Steven Chapman, sold a portion of his common stock holdings on July 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold a portion of their common stock holdings on July 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.